Is Amgen Still a Top Dividend Stock?
The relationship between interest rates and dividend stocks tends to follow a predictable pattern. When the Federal Reserve signals a shift toward monetary easing, investors often rotate toward stable, high-yielding equities that can provide both income and potential appreciation.
(NASDAQ: AMGN) offers an intriguing test case for this dynamic heading into 2025. The biotech-giant's shares have slumped 3.37% in 2024, while the S 500 has surged 26.8% as of this writing, creating what might be a compelling entry point ahead of what could prove to be a long-winded rate-cutting cycle.
Image source: Getty Images.
Source Fool.com
Amgen Inc. Stock
The stock is one of the favorites of our community with 42 Buy predictions and 4 Sell predictions.
On the other hand, the target price of 340 € is below the current price of 362.45 € for Amgen Inc., so the potential is actually -6.19%.


